ArticleInternational journal of general medicine2025
Impact of an Infective Endocarditis Team on Management and Outcomes: A Retrospective Cohort Study.
Article in International journal of general medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Purpose: Multidisciplinary team approaches have been reported to improve the management of infective endocarditis (IE). This study evaluated changes in management and outcomes after the establishment of an IE team at a tertiary care facility in Japan. Patients and Methods: A retrospective study was conducted on inpatients aged ≥18 years with definite IE between November 2015 and October 2023. The primary outcome was 90-day all-cause mortality. Secondary outcomes included in-hospital mortality, unplanned cardiac surgery, new cerebral embolism, bacteremia relapse within 90 days of admission, and duration of antibiotic therapy. Outcomes were compared between patients admitted before (control period) and after (intervention period) the implementation of the IE team in November 2019. Results: Characteristics were comparable between the two periods. No significant differences were found in 90-day mortality (15.2% vs 17.0%, Conclusion: Although no significant differences were observed in 90-day mortality, the rate of unplanned surgery was significantly lower in the intervention period, supporting the usefulness of an IE team. The longer duration of antibiotic therapy in the intervention period may reflect a higher prevalence of complicated infections including muscle abscesses.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.